- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05058989
The Evaluation of the Pathophysiology of Varicose Veins in Pregnancy
Study Overview
Status
Conditions
Detailed Description
Initially, patients will be approached by a member of the direct care team in the Maternity outpatients' departments in the following hospitals: West Middlesex hospital, Queen Charlotte's and Chelsea hospital and St Mary's hospital. This will be managed by experienced research professionals in the area of vascular surgery. If a patient is prepared to discuss their potential role in this research, then the researchers will discuss the study and recruitment details at the patient's convenience. Recruitment is completely voluntary and will not affect their routine care, this will be made clear during the discussion regarding the research, and again during the consenting process. Time will be made available for any questions and for the patient to consider recruitment in their own time. Patients will be required to consent before any study-related procedures are carried out. Then her personal identifiable data will be coded and pseudonymised.
The recruited patient will be interviewed to obtain clinical information that is essential for robust analysis. This clinical information will include standard demographic form which will be used for all patients in each follow up in order to record and gather important information which represents the composition of the target population. Gathered data will include patients' details; patients name, day of visit, hospital name, ID number, date of birth. Furthermore, this demographic form will record potential risk factors which may associate with VV development such as race, number of pregnancies, family history of venous disease, BMI which include weight and height, occupational factors, smoking, alcohol consumption and diet. Any complications arising from pregnancy will be also recorded. Finally, this proposed study will only record fetal weight in second and third trimester to correlate increased fetal weight with potential venous pathology.
First, patients will be asked to fill the demographic form then will be asked to stand on a scale to measure the weight. Height will be recorded by bringing the horizontal measure down to rest on the top of the participants head. Following this, patient will be asked to sit while measurements are recorded in a relevant source data sheet.
Next, the patient will be asked to stand on a step facing the sonographer to assess the incidence of varicose veins using Duplex ultrasound (DUS) and vector flow imaging (VFI). While patient is standing, Truncated cone tool will be performed immediately by measuring leg circumferences in each segments of each limb to produce accurate measurements of lower limbs volume. Following this, patient will be asked to sit on a chair for perform Iliac vein compression test (venous outflow function) using photoplethysmography (PPG) technique. Finally, patient's quality of life assessment will be evaluated by using Aberdeen Varicose Veins Questionnaire (AVVQ) check list. Thereafter, the patient will be thanked for their participation and excused.
Clinical Laboratory tests will be managed and performed by experienced research professionals in the area of vascular surgery. Four appointments will be arranged for each patient to investigate DNA genomic testing and Estriol (E3) and progesterone hormonal testing. First appointment during first trimester will include both genomic DNA and hormonal blood tests. The three remaining appointments in the second trimester, third trimester and three months after giving birth will include hormonal blood samples only. Patients will be entitled to exit the study at any time without providing a reason, this is clearly stated on our information sheet and consent form. Verbal consent will be requested before all follow-up ultrasound scans.
Researchers will ensure that demographic data, ultrasound data, lower limb volume and iliac vein compression measurements, histopathological results and quality of life assessment results will be collected and stored in such a way that confidentiality is preserved. All data will be pseudonyms by replacing names with research codes and by keeping any identifying information separate from the main dataset.
The data will be analysed with the help of the Imperial College statistics department. The results of this study may be presented at local, national or international meetings or submitted for publication in a peer-reviewed journal. From a patient's perspective, all data will be pseudonyms before the statistical analysis phase of the study and plans to publish the results of the study are made clear in our patient information sheet.
Data and all appropriate documentation will be stored for a minimum of 10 years after the completion of the study, including the follow-up period.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Reem Alturki, MSc
- Phone Number: +44 20 3313 1541
- Email: r.alturki18@imperial.ac.uk
Study Locations
-
-
-
London, United Kingdom, W12 0HS
- Imperial College London
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who are willing to be followed up for 1 year and agreeing to give the informed consent will be included in the inclusion criteria.
Exclusion Criteria:
- Any incomplete cases such as intrauterine death.
- Participants who fail to attend the scans after their first visit will be excluded.
- Patients with congenital vascular abnormalities/syndromes such as Klippel Klippel-Trenaunay syndrome.
- Patients who are unable to provide consent.
- Anyone who are taking part in any other research.
Potential participants who might not adequately understand verbal explanations or written information given in English, or who have special communication needs.
- Patients with signs of acute deep vein thrombosis.
- Patient suffered from severe injury of their great-saphenous vein
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pregnant women who are aged between 18 to 47 years old (childbearing age).
These patients must be willing to be followed up for 1 year and agreeing to give the informed consent.
Recruitment period will take up to three months.
Follow up period will be conducted at the end of first, second and third trimester and three months after giving birth.
|
PPG is a non-invasive method used to evaluates the severity venous reflux by measuring the venous refiling time (VRT).The principal of PPG works by using a small light source and a photoelectric cell attached to the skin in the medial supramalleolar area of the leg (the distal lower medial area of the leg).
Other Names:
First trimester (0-13 weeks):
Second trimester (14-26 weeks):
Third trimester (27-40 weeks): Same as second trimester Three months after giving birth: Same as second trimester |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The patency of the vein, the blood flow direction (antegrade/retrograde) and the peak reflux velocity are evaluated by Duplex ultrasound parameters.
Time Frame: 1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Blood vein has to be patent to exclude blood clots, blood flow direction has to be antegrade to exclude backward flow (reflux) and peak reflux velocity has to be less than 0.5 seconds to be considered normal.
|
1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The patency of the vein, the blood flow direction (antegrade/retrograde) and the peak reflux velocity are evaluated by Vector flow imaging.
Time Frame: 1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Blood vein has to be patent to exclude blood clots, blood flow direction has to be antegrade to exclude backward flow (reflux) and peak reflux velocity has to be less than 0.5 seconds to be considered normal.
|
1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Measuring the lower limb volume by Truncated cone tool.
Time Frame: 1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Measuring legs circumferences at two points C1 and C2 and the height between them (H) and then applying an equation.
|
1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Measuring the iliac vein compression using the PPG technique.
Time Frame: 1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
This technique measures the severity of venous reflux by measuring Venous refiling time (VRT) , (Abnormal less than 20 sec).
|
1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Genomic blood test
Time Frame: Through study completion, an average of 1 year.
|
Using a blood sample to assess the patient DNA (to analyze genes that associate with the development of varicose veins ) and correlating these findings with the UK biobank study.
|
Through study completion, an average of 1 year.
|
Hormonal blood test
Time Frame: 1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Using a blood sample to assess two hormones (Estriol (E3) and progesterone serum levels.
|
1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
The impact of varicose veins on the patient quality of life
Time Frame: 1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Patient's quality of life will be measured using Aberdeen varicose vein questionaire (AVVQ).
|
1 year, in each follow up (first, second, third trimester and three months after giving birth)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Mohammed Aslam, PhD, Academic Supervisor
Publications and helpful links
General Publications
- Evans CJ, Fowkes FG, Hajivassiliou CA, Harper DR, Ruckley CV. Epidemiology of varicose veins. A review. Int Angiol. 1994 Sep;13(3):263-70.
- Ismail L, Normahani P, Standfield NJ, Jaffer U. A systematic review and meta-analysis of the risk for development of varicose veins in women with a history of pregnancy. J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):518-524.e1. doi: 10.1016/j.jvsv.2016.06.003. Epub 2016 Aug 4.
- Fukaya E, Flores AM, Lindholm D, Gustafsson S, Zanetti D, Ingelsson E, Leeper NJ. Clinical and Genetic Determinants of Varicose Veins. Circulation. 2018 Dec 18;138(25):2869-2880. doi: 10.1161/CIRCULATIONAHA.118.035584.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20HH5790
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varicose Veins
-
EMSWithdrawn
-
EMSWithdrawn
-
I-VASC S.r.lRecruiting
-
Acotec Scientific Co., LtdZhejiang UniversityCompletedVaricose Veins of Lower LimbChina
-
Beijing Tsinghua Chang Gung HospitalActive, not recruiting
-
Oulu University HospitalCompletedVaricose Veins | Varicose Veins of Lower LimbFinland
-
Kahramanmaras Sutcu Imam UniversityUnknown
-
Helsinki University Central HospitalActive, not recruiting
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingVaricose Veins of Lower LimbChina
-
Worcestershire Acute Hospitals NHS TrustCompletedVaricose Veins of Lower LimbUnited Kingdom
Clinical Trials on Advanced ultrasound measurements (Duplex ultrasound (DUS) and Vector flow imaging (VFI)
-
Rijnstate HospitalRadboud University Medical CenterRecruitingCarotid Artery StenosisNetherlands
-
Radboud University Medical CenterNetherlands Organisation for Scientific ResearchRecruitingCarotid Artery StenosisNetherlands
-
Biotronik AGActive, not recruitingPeripheral Arterial DiseaseAustralia, Belgium, France, Germany, Austria, Spain
-
Rijnstate HospitalCompleted
-
Hospices Civils de LyonRecruitingUltrasound and MRI Measurement of Quadriceps Femoris Muscle in Critically Ill Children (Echo-QF-IRM)Quadriceps Femoris Measurement as a Surrogate of Muscle Mass Assessment in Critically Ill ChildrenFrance
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Philips HealthcareCompletedCardiac Output, Low | Cardiac Output, HighNetherlands
-
St George's, University of LondonUnknownEndothelial Function and Arterial StiffnessUnited Kingdom
-
Institut de Myologie, FranceCompleted